These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20140344)

  • 1. Knowledge industry: a powerful mechanism.
    Miguelote VR; Camargo KR
    Rev Saude Publica; 2010 Feb; 44(1):190-6. PubMed ID: 20140344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of pharmaceutical industry funding on clinical research.
    Lexchin JR
    Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can a good tree bring forth evil fruit? The funding of medical research by industry.
    Capps B
    Br Med Bull; 2016 Jun; 118(1):5-15. PubMed ID: 27151955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Big Pharma: a former insider's view.
    Badcott D
    Med Health Care Philos; 2013 May; 16(2):249-64. PubMed ID: 22351152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical ethics, research and the pharmaceutical industry.
    Abud-Mendoza C
    Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicine and the pharmaceutical industry.
    Baxter P
    Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
    [No Abstract]   [Full Text] [Related]  

  • 7. Industry and medicine: conflicting interests and the power of money.
    Popovsky MA; Garcia N
    Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103
    [No Abstract]   [Full Text] [Related]  

  • 8. The pipeline and the porcupine: alternate metaphors of the physician-industry relationship.
    Mather C
    Soc Sci Med; 2005 Mar; 60(6):1323-34. PubMed ID: 15626527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fostering innovation without compromising integrity.
    Pizzo PA
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S10-1; discussion 16-22. PubMed ID: 17469467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry funded clinical trials: bias and quality.
    Del Parigi A
    Curr Med Res Opin; 2012 Jan; 28(1):23-5. PubMed ID: 22103762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the need for probity when physicians interact with industry.
    Scott IA
    Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corporate Funding for Schools of Public Health: Confronting the Ethical and Economic Challenges.
    Bayer R; Sampat BN
    Am J Public Health; 2016 Apr; 106(4):615-8. PubMed ID: 26890166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical research and industrial sponsoring: avenues towards transparency and credibility.
    Hildebrandt M; Ludwig WD
    Onkologie; 2003 Dec; 26(6):529-34. PubMed ID: 14709925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol research and the alcoholic beverage industry: issues, concerns and conflicts of interest.
    Babor TF
    Addiction; 2009 Feb; 104 Suppl 1():34-47. PubMed ID: 19133913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovation and industry-academia interactions: where conflicts arise and measures to avoid them.
    Vagelos PR
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S12-3; discussion 16-22. PubMed ID: 17469468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Private-sector research ethics: marketing or good conflicts management? The 2005 John J. Conley Lecture on Medical Ethics.
    Dresser R
    Theor Med Bioeth; 2006; 27(2):115-39. PubMed ID: 16699963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovation incentives or corrupt conflicts of interest? Moving beyond Jekyll and Hyde in regulating biomedical academic-industry relationships.
    Taylor PL
    Yale J Health Policy Law Ethics; 2013; 13(1):135-97. PubMed ID: 23815042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of the public and private sectors in drug development: boundaries to protect scientific values while preserving innovation.
    Cassell GH
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S45-8; discussion S51-9. PubMed ID: 17469473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trust, but verify.
    Nature; 2009 Sep; 461(7262):315. PubMed ID: 19759574
    [No Abstract]   [Full Text] [Related]  

  • 20. Economic efficiency of countries' clinical review processes and competitiveness on the market of human experimentation.
    Ippoliti R
    Value Health; 2013; 16(1):148-54. PubMed ID: 23337226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.